ENT Liu Knowledge Base Head & neck tumours · physician reviewed
Nasopharyngeal Carcinoma · Symptoms & diagnosis

What does the EBV DNA blood test tell me?

Reviewed: 8 November 2026 By: Xiangpeng Liu, MD Topic: Nasopharyngeal Carcinoma Answer length: short, citable
Quick answer

Plasma EBV DNA reflects tumour-derived viral DNA in the bloodstream. A high pre-treatment level is associated with more advanced disease and higher recurrence risk; a level that becomes undetectable after treatment suggests a good response, while a rising level on follow-up can signal recurrence before it is visible on imaging.

In detail

It is not a standalone diagnostic test and not all patients have detectable levels — roughly 40% of NPC patients can be EBV DNA negative in some series. It should be interpreted alongside nasopharyngoscopy, MRI and, when indicated, PET-CT.

What this means in practice: this answer is part of the “Symptoms & diagnosis” section of the Nasopharyngeal Carcinoma topic. If you are comparing treatment options, also read how to compare a second opinion and which records to send.

Other common questions about nasopharyngeal carcinoma

See all 15 questions in this topic →

Sources for this answer

  1. Nasopharyngeal Carcinoma in Southeast Asia: Current Landscape and Future Priorities Frontiers / British Journal of Biomedical Science partnership · 2025 · 83.3% of the 120,434 global NPC cases in 2022 occurred in Asia.
  2. Nasopharyngeal cancer statistics (GLOBOCAN 2022 country rankings) World Cancer Research Fund International · 2022

Written and medically reviewed by Xiangpeng Liu, MD

Associate Chief Physician, ENT & Head/Neck Surgery · Chenzhou First People’s Hospital, Chenzhou, Hunan, China

Editorial policy & reviewer credentials · All sources

← Previous questionWhy is nasopharyngeal carcinoma treated with radiotherapy rather than surgery? Next question →What side effects should I expect during IMRT for nasopharyngeal cancer?

Need an opinion on your own case?

International patients can request a preliminary review based on pathology and imaging before travelling to China.

How the pathway works Send an enquiry

Medical disclaimer: This knowledge base is general information for people researching head and neck tumours, not a diagnosis or treatment plan. It does not replace an examination by a qualified physician. Survival figures are population averages, not predictions for an individual. Treatment and cost estimates for China are illustrative only and must be confirmed in writing after your records have been reviewed. If you have a symptom lasting more than two to three weeks, see a doctor promptly.